To understand if the expression of ZNF217 and its modulation by the tested compounds were limited to OCI cells, three independent experiments were performed on four additional cell lines, namely the chronic lymphatic leukemia cell lines PGA1 and MEC1, the monocytic lymphoma cell line U937, and the T-cell lymphoma cell line Jurkat. This evidence concerns the gene ZNF217 and T-cell non-Hodgkin lymphoma.